+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Anti-snoring Device Market - Consumer Trends & Forecast 2026-2034

  • PDF Icon

    Report

  • 200 Pages
  • September 2026
  • Region: Europe
  • Renub Research
  • ID: 6101911

Europe Anti-snoring Device Market Size and Forecast 2026-2034

Europe Anti-snoring Device Market is expected to reach US$ 987.03 Million by 2034 from US$ 520.89 Million in 2025, with a CAGR of 7.36% from 2026 to 2034. The Europe anti-snoring device market is growing due to rising awareness of sleep disorders, increasing prevalence of obstructive sleep apnea, growing adoption of non-invasive treatment options, technological advancements in oral appliances and wearables, and expanding access to sleep healthcare services.

Europe Anti-snoring Device Industry Overview

Anti-snoring devices are products designed to reduce or eliminate snoring by improving airflow through the upper airway during sleep. These devices include mandibular advancement devices (MADs), tongue-stabilizing devices, nasal dilators, chin straps, positional therapy devices, and smart wearable solutions. They are commonly used by individuals suffering from primary snoring and mild-to-moderate obstructive sleep apnea (OSA). Anti-snoring devices offer a non-invasive alternative to surgical procedures and continuous positive airway pressure (CPAP) therapy. Increasing awareness regarding the health risks associated with untreated snoring, coupled with technological advancements and growing demand for home-based sleep solutions, is driving market adoption across Europe.

The Europe anti-snoring device market is experiencing steady growth due to the increasing prevalence of sleep-disordered breathing conditions and rising awareness regarding sleep health. A growing elderly population, increasing obesity rates, and higher diagnosis rates of obstructive sleep apnea are expanding the target patient population. Consumers are increasingly seeking comfortable, non-invasive alternatives to CPAP therapy, driving demand for oral appliances, positional therapy devices, and smart sleep technologies. Additionally, advancements in digital dentistry, 3D printing, wearable sensors, and customized oral devices are enhancing treatment effectiveness and patient compliance. Expanding telehealth services and improved access to sleep disorder management are further supporting market growth across Europe.

Recent Developments in Europe Anti-snoring Device Market

  • Following FDA 510(k) clearance, SnoreLessNow introduced the Anti Snore Mouth Guard+, marketed in Europe as SomnoFit-S®. The mandibular advancement device is designed to gently reposition the lower jaw forward during sleep, helping to maintain an open airway and reduce snoring. The product provides a comfortable, non-invasive alternative to CPAP therapy for individuals seeking effective snoring management without the use of masks or powered equipment.

Growth Drivers for the Europe Anti-snoring Device Market

Increasing Demand for Comfortable and Customizable Oral Appliances

The growing preference for comfortable and personalized anti-snoring solutions is a major driver of the European market. Traditional snoring treatments often suffer from low patient compliance due to discomfort and inconvenience. As a result, manufacturers are increasingly focusing on customized oral appliances that provide improved fit, comfort, and effectiveness. Digital dentistry and advanced manufacturing technologies are enabling the production of highly individualized devices that can be tailored to patient-specific anatomical requirements. These innovations improve treatment adherence and clinical outcomes while supporting broader adoption among individuals seeking non-invasive snoring management options. Growing consumer awareness of sleep quality and the availability of direct-to-consumer solutions are also contributing to increased demand across Europe.

In December 2024, ZQuiet introduced the ZQuiet Advance Anti-Snoring Mouthpiece, featuring an adjustable custom-fit design and enhanced comfort-focused engineering to improve snoring relief and user compliance.

Advancements in Digital and 3D-Printed Sleep Therapy Devices

Technological innovation is transforming the anti-snoring device market through the introduction of digitally designed and 3D-printed treatment solutions. Advanced manufacturing techniques improve precision, customization, and patient comfort while reducing production time. These innovations enable healthcare providers to deliver more effective oral appliances with enhanced durability and fit. The adoption of digital workflows in dentistry and sleep medicine is also supporting wider use of customized snoring management devices. As patients increasingly seek discreet and convenient treatment options, manufacturers are investing in next-generation products that combine advanced materials with digital design capabilities. This trend is expected to accelerate market growth throughout Europe.

In May 2024, Glidewell launched the Digital Silent Nite® 3D Sleep Appliance, a fully digital, 3D-printed mandibular advancement device developed to alleviate snoring and mild-to-moderate obstructive sleep apnea.

Growing Adoption of Innovative Sleep Apnea and Snoring Therapies

The increasing need for alternatives to CPAP therapy is driving demand for innovative anti-snoring and sleep apnea treatments. Patients are seeking solutions that offer greater comfort, mobility, and long-term adherence. Manufacturers are responding by introducing advanced oral appliances, neuromodulation systems, and integrated sleep technologies that address both snoring and obstructive sleep apnea. Rising diagnosis rates and growing investments in sleep medicine are supporting the adoption of these solutions across Europe. As healthcare providers focus on improving patient outcomes through personalized therapies, the market is witnessing increased demand for innovative treatment options.

In December 2024, Nyxoah announced the commercial launch of its Genio® therapy in England, providing patients with an innovative neurostimulation-based treatment option for obstructive sleep apnea and related snoring conditions.

Challenges in the Europe Anti-snoring Device Market

Limited Consumer Awareness and Underdiagnosis

A major challenge facing the European anti-snoring device market is the underdiagnosis of sleep-related breathing disorders. Many individuals consider snoring a lifestyle issue rather than a medical condition, delaying diagnosis and treatment. Consequently, a significant proportion of potential users remain unaware of available treatment options. Additionally, access to sleep studies and specialist consultations varies across European countries, leading to differences in diagnosis rates. Limited public understanding of the relationship between chronic snoring and obstructive sleep apnea further restricts market penetration. Improving education regarding sleep health and expanding screening initiatives will be important for increasing adoption of anti-snoring devices across the region.

Product Compliance and Comfort Concerns

Although anti-snoring devices offer non-invasive treatment options, maintaining long-term patient compliance remains challenging. Some users experience discomfort, jaw soreness, nasal irritation, or difficulty adapting to oral appliances and positional therapy devices. These issues may reduce treatment adherence and lead patients to discontinue use. Individual anatomical differences can also influence device effectiveness, creating variability in treatment outcomes. Furthermore, consumers may be hesitant to invest in premium products without clear evidence of long-term benefits. Manufacturers must continue improving device design, customization, and comfort while providing clinical evidence supporting effectiveness to encourage sustained usage and strengthen market acceptance.

France Anti-snoring Device Market

France is a significant market for anti-snoring devices due to growing awareness of sleep apnea, rising obesity rates, and increasing utilization of sleep diagnostic services. Demand is particularly strong for oral appliances and neurostimulation therapies that offer alternatives to CPAP treatment. The country's well-established healthcare system and growing focus on sleep health are supporting adoption of innovative snoring management solutions.

In July 2024, Inspire Medical Systems announced the nationwide reimbursement and commercialization expansion of Inspire® Therapy in France. The implantable hypoglossal nerve stimulation device is designed for patients with moderate-to-severe obstructive sleep apnea who are unable to tolerate CPAP therapy. The reimbursement approval significantly expanded patient access to the therapy across France.

Germany Anti-snoring Device Market

Germany remains the largest anti-snoring device market in Europe, supported by a strong sleep medicine infrastructure, widespread diagnosis of sleep disorders, and high adoption of advanced treatment technologies. The country has numerous accredited sleep laboratories and specialized clinics that facilitate the use of oral appliances and innovative sleep therapies. Growing awareness of the health risks associated with untreated snoring continues to drive demand.

In October 2025, Smartee launched the Smartee Sleep Aligner, the world's first clear aligner designed to address primary snoring and obstructive sleep apnea while simultaneously providing orthodontic correction. The product offers a discreet and patient-friendly treatment option that aligns with Germany's growing demand for innovative oral sleep therapies.

Italy Anti-snoring Device Market

Italy's anti-snoring device market is expanding due to increasing awareness of sleep health, rising prevalence of obesity-related sleep disorders, and growing acceptance of non-invasive treatment options. Oral appliance therapy is gaining traction among patients seeking alternatives to CPAP treatment. Technological advancements in customized dental sleep devices are also supporting market development.

In July 2025, Vivos Therapeutics received expanded commercialization support for its VidaSleep™ Oral Appliance, a patented device developed for the treatment of snoring and mild-to-moderate obstructive sleep apnea. The appliance utilizes the company's proprietary technology to improve airway function and supports the growing adoption of oral appliance therapy across European markets, including Italy.

Spain Anti-snoring Device Market

Spain is experiencing increasing demand for anti-snoring devices due to rising awareness of sleep-disordered breathing, growing healthcare expenditure, and increasing adoption of home-based sleep solutions. Consumers are showing greater interest in convenient and non-invasive technologies that improve sleep quality and reduce snoring. Expanding sleep clinic networks are also supporting market growth.

In November 2025, Quiet Lab announced the launch of the Quiet Lab Mouthpiece, a scientifically engineered anti-snoring oral device developed to improve nighttime airflow and reduce snoring. The product incorporates advanced dental biomechanics and respiratory science principles to provide a comfortable, non-powered solution for snoring management. The launch strengthens the availability of innovative oral anti-snoring devices in European markets, including Spain.

Europe Oral Anti-Snoring Appliances Market

The Europe Oral Anti-Snoring Appliances market is experiencing steady growth due to increasing awareness of sleep-disordered breathing and the rising preference for non-invasive treatment options. Oral appliances, particularly mandibular advancement devices (MADs) and tongue-retaining devices, are widely used to reduce snoring by maintaining an open airway during sleep. These devices are gaining popularity among patients with primary snoring and mild-to-moderate obstructive sleep apnea who seek alternatives to continuous positive airway pressure (CPAP) therapy. Advances in digital dentistry, 3D scanning, and customized appliance manufacturing have improved comfort, fit, and treatment effectiveness. Additionally, increasing involvement of dentists in sleep medicine and growing acceptance of oral appliance therapy are supporting market expansion across Europe throughout the forecast period.

Europe Anti-Snoring Devices Retail Pharmacies Market

The Europe Anti-Snoring Devices Retail Pharmacies market represents an important distribution channel, driven by the accessibility and convenience offered by retail pharmacy networks. Consumers frequently purchase over-the-counter anti-snoring products such as nasal dilators, nasal strips, chin straps, and entry-level oral appliances through pharmacy outlets. Retail pharmacies provide consumers with easy access to snoring management solutions without requiring specialist consultations, making them a preferred purchasing channel for mild snoring cases. Growing consumer awareness of sleep health and increasing demand for self-care products are supporting sales through pharmacy chains across Europe. Furthermore, pharmacists play a valuable role in educating consumers about available treatment options and guiding product selection, contributing to the continued growth of this market segment.

Europe Homecare Anti-Snoring Devices Market

The Europe Homecare Anti-Snoring Devices market is growing rapidly as consumers increasingly seek convenient and cost-effective solutions for managing snoring and mild sleep-disordered breathing conditions at home. Homecare devices include oral appliances, nasal dilators, positional therapy products, chin straps, wearable sleep monitors, and other non-invasive solutions designed for independent use. Rising awareness regarding the impact of poor sleep quality on overall health is encouraging consumers to adopt home-based treatment options. The expansion of e-commerce platforms and direct-to-consumer sales channels has further improved product accessibility across Europe. In addition, technological advancements in smart sleep devices and connected monitoring systems are enhancing user experience and treatment effectiveness. These factors continue to support strong growth within the European homecare anti-snoring devices market.

Research Methodology of the Europe Anti-snoring Device Market

Step 1: Market Definition and Scope

  • The Europe Anti-Snoring Device Market was defined based on devices specifically designed to reduce, manage, or prevent snoring.
  • The scope included:
  • Mandibular advancement devices (MADs)
  • Nasal dilators
  • Nasal strips
  • Nasal clips
  • Tongue-retaining devices
  • Chin straps
  • Positional therapy devices
  • Anti-snoring pillows and specialized positioning products
  • Wearable anti-snoring devices
  • Electronic anti-snoring devices
  • Other anti-snoring devices and accessories
  • Continuous positive airway pressure (CPAP) systems were excluded because CPAP is primarily used to treat obstructive sleep apnea rather than being a conventional anti-snoring product.
  • General sleep products, including ordinary pillows, mattresses, and unrelated sleep-tracking devices, were excluded unless they had a specific anti-snoring function.
  • Products marketed for both snoring and obstructive sleep apnea were included only to the extent that their value could be attributed to anti-snoring applications.

Step 2: Estimate the Potential Snoring Population

  • The estimation began by determining the population experiencing habitual or clinically relevant snoring across European countries.
  • Key variables included:
  • Adult population
  • Male and female population
  • Age distribution
  • Overweight and obesity prevalence
  • Sleep-disordered breathing
  • Obstructive sleep apnea prevalence
  • Household awareness of snoring
  • Diagnosis and treatment rates
  • Country-level estimates were developed for:
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Netherlands
  • Switzerland
  • Belgium
  • Sweden
  • Denmark
  • Norway
  • Austria
  • Other European countries
  • The potential snoring population was subsequently narrowed to individuals representing a realistic addressable market for anti-snoring devices.

Step 3: Determine the Addressable Device Population

  • Not every person who snored was assumed to purchase an anti-snoring device.
  • The population was filtered through successive stages: Total Adult Population → Estimated Snoring Population → Habitual/Problem Snoring Population → Awareness of Snoring → Treatment-Seeking Population → Device-Eligible Population → Anti-Snoring Device Users
  • This approach prevented the market from being overstated by applying device prices to the entire snoring population.

Step 4: Estimate Device Adoption

  • Actual device users were estimated by applying adoption rates to the addressable population. Anti-Snoring Device Users = Addressable Snoring Population × Device Adoption Rate
  • Adoption rates were estimated separately by:
  • Country
  • Device category
  • Consumer segment
  • Key assumptions included:
  • Consumer awareness
  • Physician recommendations
  • Dental consultations
  • Sleep-clinic referrals
  • Online availability
  • Pharmacy distribution
  • Insurance/reimbursement
  • Disposable versus reusable products
  • Consumer willingness to purchase
  • Product effectiveness
  • Product pricing

Step 5: Apply Device Utilization and Replacement Frequency

  • Annual device requirements were estimated after determining the number of active users.
  • For reusable products: Annual Units = Active Users × Replacement Frequency
  • For disposable or frequently replaced products: Annual Units = Active Users × Annual Consumption per User
  • Different replacement cycles were applied to:
  • Mandibular advancement devices
  • Nasal strips
  • Nasal dilators
  • Electronic devices
  • Other anti-snoring products

Step 6: Establish Average Selling Price

  • An average selling price was established for each anti-snoring device category.
  • Pricing was differentiated according to:
  • Device type
  • Brand
  • Product quality
  • Prescription versus OTC
  • Custom versus ready-made device
  • Country
  • Online versus offline channel
  • Dental-clinic versus retail sales
  • Disposable versus reusable products
  • A weighted ASP was calculated using: Weighted ASP = Σ (Product Units × Product ASP) ÷ Total Product Units
  • Manufacturer and distributor prices were used where available for market-value calculations.
  • Retail prices were used as supporting references.

Step 7: Build the Bottom-Up Market Estimate

  • The bottom-up approach was used as the primary market-estimation methodology.
  • The core calculation was: Europe Anti-Snoring Device Market = Σ (Users × Annual Device Requirement per User × ASP)
  • The calculation was performed separately for:
  • Mandibular advancement devices
  • Nasal devices
  • Tongue-retaining devices
  • Positional devices
  • Electronic/wearable devices
  • Other anti-snoring devices
  • Country-level estimates were then aggregated to determine the overall European market.

Step 8: Estimate the Mandibular Advancement Device Market Separately

  • MADs were modelled separately because their purchasing pathway and ASP differed significantly from inexpensive OTC products such as nasal strips.
  • The calculation considered: Eligible Snoring/OSA Population × MAD Adoption Rate × Annual Replacement Requirement × Average MAD Price
  • The analysis differentiated between:
  • Custom-made MADs
  • Thermoplastic/boil-and-bite devices
  • Dentist-fitted devices
  • OTC MADs
  • Dental-clinic distribution and physician/sleep-specialist recommendations were incorporated into the adoption model.

Step 9: Estimate Nasal Anti-Snoring Devices

  • Nasal products were estimated using a consumption-based approach.
  • Number of Users × Average Products Used per Year × Average Selling Price
  • For reusable nasal dilators, replacement frequency was applied.
  • For disposable nasal strips, annual consumption was estimated based on the average number of strips used per week or month.
  • This category was modelled separately because:
  • Unit prices were substantially lower.
  • Purchase frequency could be significantly higher.
  • Products could be widely distributed through retail and e-commerce channels.

Step 10: Estimate Positional and Electronic Devices

  • Positional therapy and electronic anti-snoring devices were estimated based on users adopting technology-based approaches.
  • The model incorporated:
  • Device installations
  • Wearable adoption
  • Replacement cycles
  • Technology upgrades
  • Average selling price
  • Smartphone connectivity
  • Sleep-monitoring functionality
  • Products marketed for both snoring reduction and sleep monitoring were included only to the extent that their value could reasonably be attributed to anti-snoring applications.

Step 11: Retail and Distribution Channel Validation

  • The bottom-up estimate was validated through channel-level sales analysis.
  • Channels assessed included:
  • Pharmacies
  • Hospitals
  • Dental clinics
  • Sleep clinics
  • Specialty medical-device stores
  • Supermarkets
  • E-commerce
  • Manufacturer websites
  • Other retail channels
  • For each channel, the analysis considered:
  • Number of products sold
  • Average selling price
  • Distribution margins
  • Product mix
  • E-commerce was separately assessed because nasal strips, OTC MADs, and other consumer products could be purchased directly by consumers.

Step 12: Company-Level Validation

  • The market estimate was cross-checked against revenues and unit sales of manufacturers and brands operating in the European anti-snoring and oral-appliance market.
  • Key indicators included:
  • Anti-snoring device revenue
  • Product sales volume
  • European revenue
  • Number of distributors
  • Dental-clinic partnerships
  • Product launches
  • E-commerce sales
  • Geographic presence
  • Manufacturing capacity
  • Where companies reported broader sleep-care or oral-health revenues, the anti-snoring component was estimated based on:
  • Product portfolios
  • Geographic exposure
  • Product mix
  • Relevant sales channels

Step 13: Sleep-Clinic and Dental-Channel Validation

  • The number of sleep clinics, dental practices, sleep specialists, and relevant healthcare professionals was used to validate the addressable market for clinically oriented devices.
  • This was particularly important for custom mandibular advancement devices, where sales could involve:
  • Dental assessment
  • Device fitting
  • Follow-up
  • Replacement
  • The methodology distinguished between:
  • Consumer-Led Purchase and Clinician-Recommended or Clinician-Fitted Purchase
  • This prevented a single adoption rate from being applied across all anti-snoring product categories.

Step 14: Top-Down Validation

  • A top-down approach was applied as an independent validation layer.
  • The primary structure was: European Sleep-Disorder/Anti-Snoring Product Market × Anti-Snoring Device Share = Europe Anti-Snoring Device Market
  • A secondary validation was based on: Estimated Snoring Population × Device Penetration × Average Annual Device Spending
  • Penetration and spending assumptions were supported by:
  • Consumer surveys
  • Clinical literature
  • Company information
  • Retail prices
  • Healthcare statistics
  • Primary research

Step 15: Regulatory Validation

  • Regulatory requirements were reviewed because anti-snoring products could fall under different regulatory categories depending on their intended purpose and claims.
  • Products classified as medical devices were assessed under the European Union's Medical Device Regulation (EU) 2017/745 (MDR).
  • The regulatory assessment considered:
  • Device safety
  • Clinical evidence
  • Conformity assessment
  • Post-market surveillance
  • EUDAMED was used as a supporting source for identifying manufacturers and medical devices placed on the EU market.
  • Relevant EUDAMED information included:
  • Actor registration
  • UDI/device registration
  • Notified bodies and certificates
  • Market-surveillance information
  • The EUDAMED implementation timeline was considered when assessing the availability and relevance of regulatory data.

Step 16: Import-Export Validation

  • Trade statistics were used as an additional supply-side validation.
  • Apparent domestic supply was calculated as: Domestic Production + Imports − Exports = Apparent Domestic Supply
  • Relevant customs classifications were reviewed for:
  • Oral appliances
  • Nasal devices
  • Medical breathing devices
  • Sleep-related devices
  • Plastic/medical appliances
  • Electronic anti-snoring devices
  • Since customs codes could include products outside the anti-snoring category, trade statistics were treated as a supporting validation source rather than the primary market-estimation method.

Step 17: Third Validation and Market Triangulation

  • The final market estimate was triangulated using three independent approaches.

A. Bottom-Up Consumer Approach: Snoring Population × Addressable Population × Adoption Rate × Device Requirement × ASP

B. Top-Down Market Approach: Sleep-Related/Medical-Device Market × Anti-Snoring Device Share

C. Supply-Side Approach: Manufacturer Revenues + Distributor Sales + Retail/E-Commerce Sales + Import/Export Data

  • Differences between the three approaches were investigated based on:
  • Medical versus consumer products
  • Prescription versus OTC devices
  • Custom versus ready-made products
  • Retail versus manufacturer pricing
  • Reusable versus disposable devices
  • Cross-border purchases
  • E-commerce sales
  • Products marketed for both snoring and sleep apnea
  • Distributor margins
  • Replacement cycles
  • The final market value was established after reconciling these differences rather than simply averaging the three estimates.

Step 18: Country-Level Market Estimation

  • The European market was estimated separately for individual countries before aggregation.
  • The country-level model considered:
  • Adult population
  • Snoring prevalence
  • Obesity prevalence
  • Sleep-disorder awareness
  • Treatment-seeking behaviour
  • Device penetration
  • Healthcare infrastructure
  • Dental-clinic availability
  • Sleep-clinic infrastructure
  • E-commerce penetration
  • Product prices
  • Reimbursement environment
  • The European market was calculated as: Germany + France + United Kingdom + Italy + Spain + Netherlands + Switzerland + Belgium + Nordics + Austria + Poland + Rest of Europe = Europe Anti-Snoring Device Market
  • Country-level estimation was important because consumer awareness, healthcare access, dental treatment pathways, and product pricing differed across European markets.

Step 19: Historical Market Estimation

  • Historical market values were estimated using:
  • Historical snoring populations
  • Device penetration
  • Unit sales
  • ASPs
  • Replacement rates
  • Company revenues
  • Retail prices
  • Distribution information
  • Historical ASPs were applied to their corresponding years rather than using current prices retrospectively.
  • Historical changes in the following factors were incorporated:
  • Consumer awareness
  • Online purchasing
  • Product availability
  • Clinical adoption of oral appliances
  • Sleep-health awareness

Step 20: Market Forecasting

  • The future Europe Anti-Snoring Device Market was forecast based on changes in:
  • Addressable snoring population
  • Device adoption
  • Replacement frequency
  • Product innovation
  • Average selling prices
  • The core forecasting formula was: Future Market = Future Active Device Users × Annual Device Requirement per User × Future ASP
  • Key forecast factors included:
  • Aging population
  • Increasing awareness of sleep-related disorders
  • Rising obesity prevalence
  • Greater awareness of snoring and sleep apnea
  • Increasing consumer interest in non-invasive solutions
  • Growth of oral appliance therapy
  • Expansion of dental sleep medicine
  • E-commerce penetration
  • Product innovation
  • Wearable technology
  • Smartphone-connected sleep devices
  • Improved clinical recognition of sleep-disordered breathing
  • Growth assumptions were applied separately by:
  • Country
  • Product category
  • Device type
  • A uniform European growth rate was avoided to reflect differences across individual markets.
  • Core Market Formula: Europe Anti-Snoring Device Market = Σ [Active Device Users × Annual Device Requirement per User × Average Selling Price]
  • The bottom-up user-based approach was used as the foundation.
  • Independent validation layers included:
  • Company revenues
  • Retail and e-commerce sales
  • Dental-clinic activity
  • Sleep-clinic activity
  • Regulatory information
  • Healthcare statistics
  • Import/export data
  • The methodology also distinguished clinically oriented devices from consumer products, which was important for accurately estimating the European anti-snoring device market.

Market Segmentations

Product

  • Oral Appliances
  • Nasal Devices
  • Tongue-Stabilizing Devices
  • Chin Straps
  • Position Control Devices
  • Expiratory Positive Airway Pressure (EPAP) Therapy Devices

Distribution Channel

  • Retail Pharmacies
  • Online Stores

End User

  • Homecare
  • Others

Countries

  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom
  • Belgium
  • Netherlands
  • Russia
  • Poland
  • Greece
  • Norway
  • Romania
  • Portugal
  • Rest of Europe

All the Key players have been covered with 5 Viewpoints

  • Overviews
  • Key Person
  • Recent Developments
  • SWOT Analysis
  • Revenue Analysis

Key Players Analysis

  • Koninklijke Philips N.V.
  • ResMed, Inc.
  • SomnoMed Limited
  • GSK Plc.
  • Apnea Sciences Corporation
  • ZQuiet (Sleeping Well, LLC)
  • Airway Management, Inc.
  • Fisher & Paykel Healthcare Limited.
  • Tomed GmbH

Table of Contents

1. Introduction
2. Research & Methodology
2.1 Data Source
2.1.1 Primary Sources
2.1.2 Secondary Sources
2.2 Research Approach
2.2.1 Top-Down Approach
2.2.2 Bottom-Up Approach
2.3 Forecast Projection Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Europe Anti-snoring Device Market
5.1 Historical Market Trends
5.2 Market Forecast
6. Market Share Analysis
6.1 By Product
6.2 By Distribution Channel
6.3 By End User
6.4 By Countries
7. Product - Historical and Current Market Trends & Forecast
7.1 Oral Appliances
7.2 Nasal Devices
7.3 Tongue-Stabilizing Devices
7.4 Chin Straps
7.5 Position Control Devices
7.6 Expiratory Positive Airway Pressure (EPAP) Therapy Devices
8. Distribution Channel - Historical and Current Market Trends & Forecast
8.1 Retail Pharmacies
8.2 Online Stores
9. End User - Historical and Current Market Trends & Forecast
9.1 Homecare
9.2 Others
10. Countries - Historical and Current Market Trends & Forecast
10.1 France
10.2 Germany
10.3 Italy
10.4 Spain
10.5 United Kingdom
10.6 Belgium
10.7 Netherlands
10.8 Russia
10.9 Poland
10.10 Greece
10.11 Norway
10.12 Romania
10.13 Portugal
10.14 Rest of Europe
11. Porter’s Five Forces Analysis
11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes
12. SWOT Analysis
12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat
13. Merger and Acquisition
14. Key Players Analysis
14.1 Koninklijke Philips N.V.
14.1.1 Overviews
14.1.2 Key Person
14.1.3 Recent Developments
14.1.4 SWOT Analysis
14.1.5 Revenue Analysis
14.2 ResMed, Inc.
14.2.1 Overviews
14.2.2 Key Person
14.2.3 Recent Developments
14.2.4 SWOT Analysis
14.2.5 Revenue Analysis
14.3 SomnoMed Limited
14.3.1 Overviews
14.3.2 Key Person
14.3.3 Recent Developments
14.3.4 SWOT Analysis
14.3.5 Revenue Analysis
14.4 GSK Plc.
14.4.1 Overviews
14.4.2 Key Person
14.4.3 Recent Developments
14.4.4 SWOT Analysis
14.4.5 Revenue Analysis
14.5 Apnea Sciences Corporation
14.5.1 Overviews
14.5.2 Key Person
14.5.3 Recent Developments
14.5.4 SWOT Analysis
14.5.5 Revenue Analysis
14.6 ZQuiet (Sleeping Well, LLC)
14.6.1 Overviews
14.6.2 Key Person
14.6.3 Recent Developments
14.6.4 SWOT Analysis
14.6.5 Revenue Analysis
14.7 Airway Management, Inc.
14.7.1 Overviews
14.7.2 Key Person
14.7.3 Recent Developments
14.7.4 SWOT Analysis
14.7.5 Revenue Analysis
14.8 Fisher & Paykel Healthcare Limited.
14.8.1 Overviews
14.8.2 Key Person
14.8.3 Recent Developments
14.8.4 SWOT Analysis
14.8.5 Revenue Analysis
14.9 Tomed GmbH
14.9.1 Overviews
14.9.2 Key Person
14.9.3 Recent Developments
14.9.4 SWOT Analysis
14.9.5 Revenue Analysis

Companies Mentioned

  • Koninklijke Philips N.V.
  • ResMed, Inc.
  • SomnoMed Limited
  • GSK Plc.
  • Apnea Sciences Corporation
  • ZQuiet (Sleeping Well, LLC)
  • Airway Management, Inc.
  • Fisher & Paykel Healthcare Limited.
  • Tomed GmbH

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...